Pharmaceuticals & Healthcare
Turkey’s pharmaceutical market became the 6th largest market in Europe and the 16th largest in the world in terms of sales back in 2012. Pharmaceutical sales reached a stunning USD 12.5 billion, which means a CAGR of nearly 10 percent between 2003 and 2012. Both local and international investors have been looking to enter into Turkish market with the investments in the pharmaceutical sector to take advantage of Turkey’s attractive market where the healthcare industry and the pharmaceutical sector grew by 5.8 percent and 8.9 percent respectively from 2012 to 2013, while the growth in real GDP was 3.5 percent for the same period.
Ketenci&Ketenci provides a wide range of services in the pharmaceuticals and healthcare sectors, from drafting and negotiating to licensing, distribution, supply and license transfer agreements. We advise our international clients on the various aspects of Turkish pharmaceutical and healthcare regulations, and assist our clients in their day-to-day business.
We also regularly advise global funds, Private Equities, hedge funds and family offices in relation to their investments and interests on Pharmaceuticals & Healthcare sector in Turkey and Europe.
Ketenci&Ketenci's pharmaceuticals and healthcare team is experienced in advising multinational pharmaceutical clients on transactions, regulatory and compliance issues specific to the pharmaceutical and medical device industry.
In addition, we also provide comprehensive litigation advice to our institutional and private clients in Turkish Pharmaceuticals & Healthcare sector.
In the pharmaceuticals and healthcare sectors, we deliver a full range of services to help clients efficiently address competition, commercial, employment, intellectual property and compliance issues.
We frequently advise on matters involving:
- Corporate matters
- Joint Ventures
- M&As
- Marketing
- Product liability
- Tender issues with regard to pharmaceutical products
- Pre-license sale of pharmaceutical product
- Turkish pharmaceutical regulations, including marketing authorization, pricing and promotion regulations